M&A Deal Summary

TXE Capital Acquires Envirodyne Laboratories

On December 31, 2021, private equity firm TXE Capital acquired life science company Envirodyne Laboratories

Acquisition Highlights
  • This is TXE Capital’s 1st transaction in the Life Science sector.
  • This is TXE Capital’s 1st transaction in the United States.
  • This is TXE Capital’s 1st transaction in Texas.

M&A Deal Summary
Date 2021-12-31
Target Envirodyne Laboratories
Sector Life Science
Buyer(s) TXE Capital
Deal Type Buyout (LBO, MBO, MBI)
Advisor(s) Generational Equity LLC (Financial)

Target

Envirodyne Laboratories

Houston, Texas, United States
Envirodyne Laboratories is a full-service NELAP accredited environmental analytical testing laboratory. Envirodyne Laboratories services include methodologies for Inductively Coupled Plasma (ICP), ICP-MS (Metals), Gas Chromatography/Mass Spectrometer (GC/MS - Organics), Ion Chromatograph (IC), Microbiology, Wet Chemistry, and more. Envirodyne Laboratories was founded in 1991 and is based in Houston, Texas.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

TXE Capital

Investor

Category Private Equity Firm
Founded 2013
Size Small
Type Sector Focused
DESCRIPTION

TXE Capital is a private investment firm focused on the buying lower middle-market companies in the laboratory, testing, and inspection sectors. TXE Capital was established in 2013 and is headquartered in Houston, Texas.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Buyout (LBO, MBO, MBI)) 1 of 1
State (Texas) 1 of 1
Country (United States) 1 of 1
Year (2021) 1 of 1
Mergr

Product

Company

Legal